Allegations Of GlaxoSmithKline (GSK) Corruption Spread To Syria
7/25/2014 5:53:46 AM
(Reuters) - GlaxoSmithKline (GSK.L) faces new allegations of corruption, this time in Syria, where the drugmaker and its distributor have been accused of paying bribes to secure business, according to a whistleblower's email reviewed by Reuters.
Britain's biggest drugmaker said on Thursday it was investigating the latest claims dating back to 2010, which were laid out in the email received by the company on July 18.
Help employers find you! Check out all the jobs and post your resume.
comments powered by